Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism PRMT1 inhibitors(Protein arginine N-methyltransferase 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H25N3O2 |
InChIKeyRITRCMIWRZBDID-UHFFFAOYSA-N |
CAS Registry792946-69-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | CN | 28 Oct 2014 | |
Breast Cancer | Preclinical | CN | 28 Oct 2014 | |
Liver Cancer | Preclinical | CN | 28 Oct 2014 |